PET NEUROIMAGING WITH [C-11] VENLAFAXINE - SEROTONIN UPTAKE INHIBITION, BIODISTRIBUTION AND BINDING IN LIVING PIG BRAIN

Citation
Df. Smith et al., PET NEUROIMAGING WITH [C-11] VENLAFAXINE - SEROTONIN UPTAKE INHIBITION, BIODISTRIBUTION AND BINDING IN LIVING PIG BRAIN, European neuropsychopharmacology, 7(3), 1997, pp. 195-200
Citations number
31
Categorie Soggetti
Neurosciences,"Clinical Neurology","Pharmacology & Pharmacy
ISSN journal
0924977X
Volume
7
Issue
3
Year of publication
1997
Pages
195 - 200
Database
ISI
SICI code
0924-977X(1997)7:3<195:PNW[V->2.0.ZU;2-2
Abstract
The brain binding kinetics and distribution of the antidepressant venl afaxine, labelled with C-11 in the O-methyl position, was studied by P ET after intravenous injection in anesthetized pigs. In addition, venl afaxine's action on serotonin (5-HT) uptake was studied in vitro in bl ood platelets obtain from humans or pigs. Venlafaxine resembled imipra mine, paroxetine and citalopram in causing a dose-dependent inhibition of 5-HT uptake in blood platelets from pigs and humans. Venlafaxine-d erived radioactivity entered the living brain readily and showed highe r binding potentials in diencephalic and telencephalic regions than in cerebellum Acute administration of an antidepressant drug (i.e. imipr amine, citalopram or paroxetine) enhanced the distribution and altered the binding of venlafaxine in certain brain regions. The findings sho w that [C-11]venlafaxine is not an ideal PET radiotracer mainly becaus e of its relatively low binding potentials and its lack of specificity for the 5-HT transporter in living brain. (C) 1997 Elsevier Science B .V.